Life science company specializing in gene therapy.
-Implementation of the Affordable Care Act of 2010 (P.L. 111-148)
-Implementation of the Orphan Drug Act of 1983 (P.L. 97-414) and orphan drug development
-Implementation of the 21st Century Cures Act (P.L. 114-255)
-Implementation of the FDA Reauthorization Act (P.L. 115-52)
-Federal funding and regulation of innovative gene therapy technologies
HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE
FOLEY HOAG LLP
1717 K Street, N.W., Suite 1200, Washington, DC, 20006, US
PAUL KIM